Supernus Pharmaceuticals shares owned by Everence Capital Management
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Everence Capital Management
from 13F filings
Historical chart of Everence Capital Management investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Everence Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Supernus Pharmaceuticals by Everence Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $219k | 7.6k | 28.93 |
2023-09-30 | $209k | 7.6k | 27.61 |
2023-06-30 | $251k | 7.6k | 33.16 |
2023-03-31 | $274k | 7.6k | 36.20 |
2022-12-31 | $270k | 7.6k | 35.67 |
2022-09-30 | $256k | 7.6k | 33.82 |
2022-03-31 | $272k | 8.4k | 32.27 |
2021-06-30 | $320k | 10k | 30.83 |
2021-03-31 | $272k | 10k | 26.20 |
2020-12-31 | $261k | 10k | 25.14 |
2020-09-30 | $216k | 10k | 20.81 |
2020-06-30 | $250k | 10k | 24.08 |
2020-03-31 | $187k | 10k | 18.02 |
2019-06-30 | $232k | 7.0k | 33.05 |
2019-03-31 | $246k | 7.0k | 35.04 |
2018-06-30 | $205k | 3.4k | 59.94 |
More positions owned by Everence Capital Management
View all positions for Everence Capital Management